|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
SCIDIR_ocn644605763 |
| 003 |
OCoLC |
| 005 |
20231117033157.0 |
| 006 |
m o d |
| 007 |
cr bn||||||abp |
| 007 |
cr bn||||||ada |
| 008 |
100629s1990 enka ob 001 0 eng d |
| 040 |
|
|
|a OCLCE
|b eng
|e pn
|c OCLCE
|d OCLCQ
|d OCLCO
|d OCLCQ
|d UIU
|d OCLCF
|d YDXCP
|d N$T
|d IDEBK
|d N$T
|d EBLCP
|d OCLCQ
|d N$T
|d OCLCQ
|d MERUC
|d OCLCQ
|d VLY
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 607671646
|a 926092706
|a 937405169
|a 1154461762
|a 1162517944
|
| 020 |
|
|
|a 9781483183626
|q (electronic bk.)
|
| 020 |
|
|
|a 1483183629
|q (electronic bk.)
|
| 020 |
|
|
|z 9780723609230
|
| 020 |
|
|
|z 0723609233
|
| 035 |
|
|
|a (OCoLC)644605763
|z (OCoLC)607671646
|z (OCoLC)926092706
|z (OCoLC)937405169
|z (OCoLC)1154461762
|z (OCoLC)1162517944
|
| 042 |
|
|
|a dlr
|
| 050 |
|
4 |
|a RM302.5
|b .F67 1989eb
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615.7/042
|2 23
|
| 245 |
0 |
0 |
|a Formulation factors in adverse reactions /
|c edited by A.T. Florence and E.G. Salole.
|
| 260 |
|
|
|a London ;
|a Boston :
|b Wright,
|c 1990.
|
| 300 |
|
|
|a 1 online resource (x, 124 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Topics in pharmacy ;
|v v. 1
|
| 588 |
0 |
|
|a Print version record.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 506 |
|
|
|3 Use copy
|f Restrictions unspecified
|2 star
|5 MiAaHDL
|
| 533 |
|
|
|a Electronic reproduction.
|b [Place of publication not identified] :
|c HathiTrust Digital Library,
|d 2010.
|5 MiAaHDL
|
| 538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
| 583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
| 505 |
0 |
|
|a Front Cover; Formulation Factors in Adverse Reactions; Copyright Page; Table of Contents; Series preface; Preface; Contributors; Chapter 1. Adverse reactions to excipients in pharmaceutical formulations; Introduction: excipients are not inactive; Spectrum and incidence of excipient reactions; Colouring agents; Other dyes; Preservatives; Other preservatives; Sugars, sweeteners and flavours; Cyclamate; Components of ointments, creams and other topical formulations; Alcohols; Problems and possible solutions; References; Further reading
|
| 505 |
8 |
|
|a Chapter 2. Drug allergy: chemical and pharmaceutical aspectsIntroduction; Immunochemical mechanisms of drug allergy; Structural properties required for eliciting antigens; Routes of formation of antigens from drugs; Direct conjugation with proteins; Reactive metabolites; Chemically reactive impurities and degradation products; Eliciting, non-reactive antigens; Polymerization of penicillins; Reactions between penicillins and pharmaceutical adjuvants; Conclusions; References; Chapter 3. Adverse reactions to parenterals; Introduction; Excipients; Co-solvents for poorly soluble drugs
|
| 505 |
8 |
|
|a AntioxidantsAntimicrobial preservatives; Miscellaneous adverse reactions to excipients; Particulates as a cause of adverse reactions to parenterals; Particles contributed by administration equipment; Administration of parenterals; Drug interactions with plastic materials; Blocking of catheters; Physical interactions with plastic syringes; Effects of injection vehicle on fluid drop size; Conclusions; References; Further reading; Chapter 4. Adverse reactions to the transit of oral dosage forms; Introduction; Drug-induced oesophageal ulceration; Factors influencing oesophageal transit
|
| 505 |
8 |
|
|a Formulation factorsDrug absorption after delayed oesophageal transit; Conclusions; References; Chapter 5. Physical properties of formulations and adverse reactions to medicines; Introduction; Ocular medication; Oral dosage forms; Parenteral therapy; Aerosols; Conclusions; References; Index
|
| 546 |
|
|
|a English.
|
| 650 |
|
0 |
|a Drugs
|x Side effects.
|
| 650 |
|
2 |
|a Drug-Related Side Effects and Adverse Reactions
|0 (DNLM)D064420
|
| 650 |
|
6 |
|a M�edicaments
|x Effets secondaires.
|0 (CaQQLa)201-0002241
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Drugs
|x Side effects
|2 fast
|0 (OCoLC)fst00898912
|
| 700 |
1 |
|
|a Florence, A. T.
|q (Alexander Taylor)
|
| 700 |
1 |
|
|a Salole, E. G.
|q (Eugene G.)
|
| 776 |
0 |
8 |
|i Print version:
|t Formulation factors in adverse reactions.
|d London ; Boston : Wright, 1990
|w (OCoLC)19399895
|
| 830 |
|
0 |
|a Topics in pharmacy ;
|v v. 1.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780723609230
|z Texto completo
|
